Alexion Pharmaceuticals Inc. (ALXN)

Index:

Nasdaq 100

$ 0.00
   
  • Closing Price Chg:
    $0.00
  • 52 Week High: $0.00
  • 52 Week Low: $0.00
  • Currency: US Dollars
  • Shares Issued: 219.50m
  • Volume: 0
  • RiskGrade: 193

Latest ShareCast News

AstraZeneca's Alexion acquisition cleared by European Commission

By Michele Maatouk

Date: Tuesday 06 Jul 2021

(Sharecast News) - AstraZeneca said on Tuesday that its $39bn proposed acquisition of US drug developer Alexion has been cleared by the European Commission.

ALXN ShareCast News

UK's CMA to probe $39bn AstraZeneca-Alexion deal 25-May-2021 ShareCast
S&P places AstraZeneca's debt on Credit Watch Po... 16-Dec-2020 ShareCast
Alexion Pharmaceuticals trading suspended after ... 12-Dec-2016 ShareCast

ALXN Newspaper Links

Abbott in $6.6 Billion Deal for Drug Unit 29-Sep-2009 New York Times
Biotech Drug Said to Be Useful Against a Rare Bl... 26-Jan-2006 New York Times

ALXN Tips & Analysis

No recent information was found.

ALXN News Wires

Alexion Pharmaceuticals, Inc. [ALXN] CEO to Ring... 27-Feb-2006 Marketwired

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

ALXN Market Data

Currency US Dollars
Share Price $ 0.00
Closing Price Change $ 0.00
% Change 0.00 %
52 Week High $0.00
52 Week Low $0.00
Volume 0
Shares Issued 219.50m
RiskGrade 193

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page